Effect of TENS in Children With Spastic Cerebral Palsy
Launched by CAIRO UNIVERSITY · Dec 12, 2022
Trial Information
Current as of February 05, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying the effects of a treatment called TENS (Transcutaneous Electrical Nerve Stimulation) on children with spastic cerebral palsy. Cerebral palsy is a condition that affects movement and muscle tone, and spasticity means that the muscles can be stiff or tight. The goal of this trial is to see if TENS can help reduce stiffness in the calf muscles of children aged 3 to 10 years who have mild to moderate muscle tone. TENS is a simple and inexpensive tool used by physiotherapists, and it has fewer side effects compared to other treatments.
To participate in this trial, children must have spastic diplegia, which means they have stiffness mostly in their legs. They should be between 3 and 10 years old and show mild to moderate muscle tone. However, children with a history of seizures, those who cannot lie on their stomach, or those who cannot feel pain will not be included. If eligible, participants can expect to receive TENS treatment and be monitored to see how it affects their muscle tone. This study is currently looking for participants, and it aims to find a safe and effective way to help manage muscle stiffness in children with cerebral palsy.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • The children will be included in this study is according to the following criteria
- • 1. Cerebral palsy spastic diaplegia.
- • 2. Their age ranged from 3-10 years.
- • 3. Both Sexes were included.
- • 4. The subjects with mild to moderate muscle tone according to MAS in which mild is 1 and 1+ , and moderate is 2.
- Exclusion Criteria:
- * The subject will be excluded if he/she has one or more of the following criteria:
- • 1. Children with a history of seizures.
- • 2. Children who could not lie prone for any cause.
- • 3. Children who could not react to pain.
- • 4. Children who had applied any surgical procedure which affect muscle tone or any inhibitory injections like BOTOX.
Trial Officials
Asmaa Osama Sayed, Phd
Study Director
Assistant Professor at Cairo university
About Cairo University
Cairo University, a premier institution in Egypt, is dedicated to advancing medical research and education through innovative clinical trials. With a strong emphasis on improving healthcare outcomes, the university collaborates with various stakeholders to conduct rigorous scientific studies that address critical health challenges. Leveraging its extensive resources and expert faculty, Cairo University aims to contribute valuable insights to the medical community and enhance patient care both locally and globally. Through its commitment to ethical research practices and excellence, the university plays a pivotal role in shaping the future of healthcare in the region.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Giza, Dokki, Egypt
People applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Discussion 0
Similar Trials